Management of male osteoporosis: Report of the UK consensus group

QJM: An International Journal of Medicine

Volumn 91, Issue 2, 1998, Pages 71-92

  Eastell, R ^a,k   Boyle, I T ^b   Compston, J ^c   Cooper, C ^d   Fogelman, I ^e   Francis, R M ^f   Hosking, D J ^g   Purdie, D W ^h   Ralston, S ⁱ   Reeve, J ^c   Reid, D M ⁱ   Russell, R G G ^a   Stevenson, J C ^j  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f FREEMAN HOSPITAL   (United Kingdom)

^g NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^h HULL ROYAL INFIRMARY   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j Wynn Inst for Metabolic Research   (United Kingdom)

^k NORTHERN GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; FLUORIDE SODIUM; TESTOSTERONE;

ALCOHOL CONSUMPTION; ALCOHOLISM; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; HIP FRACTURE; HUMAN; HYPOGONADISM; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; TRANSPLANTATION; UNITED KINGDOM; VERTEBRA FRACTURE;

EID: 0031913615     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.2.71     Document Type: Review

References (207)

1. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a world-wide projection. Osteoporosis Int 1992; 2:285-9.
2. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992; 7:221-7.
3. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995; 16:298-327.
4. Working Party. Fractured neck of femur. J R Coll Physicians Lond 1989; 23:8-12.
5. Bengnér U, Johnell O, Redlund-Johnell I. Changes in incidence and prevalence of vertebral fractures during 30 years. Calcif Tissue Int 1988; 42:293-6.
6. O'Neill TW, Varlow J, Cooper C, Felsenberg D, Silman AJ. Differences in vertebral deformity indices between 3 European populations. J Bone Miner Res 1993; 8(suppl. 1):S149.
7. Seeman E. Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities. Am J Med 1993; 95(suppl. 5A):22-85.
8. Garraway WM, Stauffer RN, Kurland LT, O'Fallon WM. Limb fractures in a defined population. I. Frequency and distribution. Mayo Clin Proc 1979; 54:701-7.
9. Dennison E, Cooper C. The epidemiology of osteoporosis. Br J Clin Pract 1996; 50:33-6.
10. Melton LJ III, Riggs BL. Epidemiology of age-related fractures. In: Avioli LV, ed. The Osteoporotic Syndrome. New York: Grune and Stratton, 1983:45-72.
11. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ and the European Vertebral Osteoporosis Study Group. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11:1010-17.
12. Lunt M, Felsenberg D, Adams J, Benevolenskaya L, Cannata J, Dequeker J, Dodenhof C, Falch JA, Johnell O, Khaw K-T, Masaryk P, Pols H, Poor G, Reid D, Scheidt-Nave C, Weber K, Silman AJ, Reeve J. Population-based geographic variations in DXA bone density in Europe: the EVOS study. Osteoporos Int 1997; 7:175-89.
13. Cooper C, Melton LJ III. Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego, Academic Press, 1996:419-34.
14. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y, Melton LJ. Comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991; 133:801-9.
15. O'Neill TW, White J, Eastell R, Siman AJ. The influence of sex on morphometric indices of vertebral deformity. J Orthop Rheumatol 1993; 6:29-32.
16. Melton LF, O'Fallon WM, Riggs BL. Secular trends in the incidence of hip fractures. Calcif Tissue Int 1987; 41:57-64.
17. Spector TD, Cooper C, Lewis AF. Trends in admissions for hip fracture in England and Wales, 1968-1985. Br Med J 1990; 300:1178-84.
18. Seeman E, Melton LJ III, O'Fallon WM, Riggs LB. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75:977-83.
19. Cooper C, Barker DJ, Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. Br Med J 1988; 297:1443-6.
20. Wickham CAC, Walsh K, Cooper C, Barker DJP, Margetts BM, Morris J, Bruce SA. Dietary calcium, physical activity, and risk of hip fracture: a prospective study. Br Med J 1989; 299:889-92.
21. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2:16-25.
22. Coupland C, Wood D, Cooper C. Physical inactivity is an independent risk factor for hip fracture in the elderly. J Epidemiol Community Health 1993; 47:441-3.
23. Peris P, Guanabens N, Monegral A, Suris X, Alvarez L, Martinez de Osaba MJ, Hernandez MV, Munoz-Gomez J. Aetiology and presenting symptoms in male osteoporosis. Br J Rheumatol 1995; 34:936-41.
24. Egger P, Fall C, Duggleby S, Hobbs R, Cooper C. Cigarette smoking and bone mineral density in the elderly. J Epidemiol Community Health 1996; 50:47-50.
25. Poor C, Atkinson EJ, O'Fallon WM, Melton LJ III. Predictors of hip fractures in elderly men. J Bone Miner Res 1995; 10:1990-7.
26. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39:766-71.
27. Santavirta S, Konttinen YT, Heliovaara M, Knekt P, Luthje P, Aromaa A. Determinants of osteoporotic thoracic vertebral fracture. Screening of 57,000 Finnish women and men. Acta Orthop Scand 1992; 63:198-202.
28. Silman AJ, O'Neill TW, Varlow JR, Agnusdei D, Cooper C, Dequeker J, Felsenberg D, Kanis JA, Kruskemper G, Raspe H and the European Vertebral Osteoporosis Study Group. Effect of physical activity on the risk of vertebral deformity. J Bone Miner Res 1995; 10:S174.
29. Heyse SP. Epidemiology of hip fractures in the elderly: a cross-national analysis of mortality rates for femoral neck fractures. Osteoporos Int 1993; suppl. 1:S16-19.
30. Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of hip: the East Anglian audit. Br Med J 1995; 310:904-8.
31. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ III. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993; 137:1001-5.
32. Black ER. Current estimates from the health interview survey; United States - 1976. Vital Health Stat 10 1977; 119:1-80.
33. Hollingworth W, Todd CJ, Parker MJ. The cost of treating hip fractures in the twenty-first century. J Public Health Med 1995; 17:269-76.
34. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993; 8:1-9.
35. Kelly PJ, Pocock NA, Sambrook PN, Eisman JA. Dietary calcium, sex hormones, and bone mineral density in men. Br Med J 1990; 300:1361-4.
36. Snow-Harter C, Whalen R, Myburgh K, Arnaud S, Marcus R. Bone mineral density, muscle strength, and recreational exercise in men. J Bone Miner Res 1992; 7:1291-6.
37. Bonjour JP, Thientz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73:555-63.
38. Reeve J, Kroger H, Nijs J, Pearson J, Felsenberg D, Reiners C, Schneider P, Mitchell A, Ruegsegger P, Zander C, Fischer M, Bright J, Henley M, Lunt M, Dequeker J. Radial cortical and trabecular bone densities of men and women standardized with the European forearm phantom. Clin Invest 1996; 58:135-43.
39. Kelly PJ, Twomey L, Sambrook PN, Eisman JA. Sex differences in peak adult bone mineral density. J Bone Miner Res 1990; 5:1169-75.
40. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992; 326:600-4.
41. Tobin JD, Fox KM, Cejku ML, Roy TA, Epstein RS, Plato CC. Bone density changes in normal men: a 4-19 year longitudinal study. J Bone Miner Res 1993; 8(suppl4):S142.
42. Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990; 112:29-34.
43. Hannan MT, Felson DT, Anderson JJ. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res 1992; 7:547-53.
44. Francis RM, Peacock M, Marshall DH, Horsman A, Aaron JE. Spinal osteoporosis in men. Bone Miner 1989; 5:347-57.
45. Mazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH. Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res 1990; 5:645-52.
46. Aaron JE, Makins NB, Sangreiya K. Microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Rel Res 1987; 215:260-71.
47. Mosekilde L. Sex differences in age-related loss of vertebral trabecular bone mass and structure-biomechanical consequences. Bone 1989; 10:425-32.
48. Orwoll ES, Deftos LJ. Serum osteocalcin (BGP) levels in normal men: a longitudinal evaluation reveals an age-associated increase. J Bone Miner Res 1990; 5:259-62.
49. Baillie SP, Davison CE, Johnson FJ, Francis RM. Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21:139-41.
50. Christian JC, Yu P-L, Slemenda CW, Johnston CC Jr. Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 1989; 44:429-33.
51. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 1992; 2:128-34.
52. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Intern Med 1995; 123:452-60.
53. Orwoll ES, Meier DE. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. Clin Endocrinol Metab 1986; 63:1262-9.
54. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994; 9:915-21.
55. Štěpán JS, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69:523-7.
56. Murphy S, Khaw K-T, Cassidy A, Compston JE. Sex hormones and bone mineral density in elderly men. Bone Miner 1993; 20:133-40.
57. Drinka PJ, Olson J, Bauwens S, Voeks SK, Carlson I, Wilson M. Lack of association between free testosterone and bone density separate from age in elderly males. Calcif Tissue Int 1993; 52:67-9.
58. Francis RM, Johnson FJ, Rawlings D. The determinants of bone mass in normal elderly men. In: Ring EFJ, ed. Current Research in Osteoporosis and Bone Mineral Measurement II. 1992 Bath Conference on Osteoporosis and Bone Mineral Measurement. London: British Institute of Radiology, 1992:54-5.
59. Cooper C, Coupland M, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54:49-52.
60. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993; 20:1666-9.
61. Saito JK, Davis JW, Wasnich RD, Ross PD. Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study. Calcif Tissue Int 1995; 57:115-19.
62. Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G. Total body calcium in rheumatoid arthritis: effects of activity and corticosteroid therapy. Br Med J 1982; 285:330-2.
63. Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis - effects of low-dose corticosteroids. Arthritis Rheum 1993; 36:222-8.
64. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Effects of corticosteroids on bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J 1986; 293:1463-6.
65. Toogood JH, Baskerville JC, Markov AE, Hodsman AB, Fraher LJ, Jennings B, Haddard RG, Drost D. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol 1995; 96:157-66.
66. Doerr P, Pirke KM. Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab 1976; 43:622-9.
67. Veldhuis JD, Lizarralde G, Iranmanesh A. Divergent effects: short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J Clin Endocrinol Metab 1992; 74:96-102.
68. MacAdams M, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104:648-51.
69. Martens HF, Sheets PK, Tenover JS, Dugowson CE, Bremner WJ, Starkebaum C. Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy. J Rheumatol 1994; 21:1427-31.
70. Morrison D, Capewell S, Reynolds SP, Thomas J, Ali NJ, Read GF, Henley R, Riad-Fahmy D. Testosterone levels during systemic and inhaled corticosteroid therapy. Respir Med 1994; 88:659-63.
71. Pocock NA, Eisman JA, Dunstan CR, Evans RA, Thomas DH, Huq NL. Recovery from steroid-induced osteoporosis. Ann Intern Med 1987; 107:319-23.
72. Goswami R, Shah P, Ammini AC, Berry M. Healing of osteoporotic vertebral compression fractures following cure of Cushing's syndrome. Australas Radiol 1995; 39:195-7.
73. Haddad G, Haddad JG, Kaplan FS. Severe symptomatic osteopenia in a man with pigmented micronodular adrenal hyperplasia. Clin Orthop 1995; 313:220-3.
74. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 110:777-82.
75. Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BE. Osteoporosis and Klinefelter's syndrome. Clin Endocrinol (Oxf) 1992; 36:13-18.
76. Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 1991; 6:39-43.
77. 6-GnRH). J Clin Endocrinol Metab 1993; 76:288-90.
78. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DL, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987; 106:354-61.
79. Kasperk C, Fitzsimmons R, Strong D. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 1990; 71:1322-9.
80. Pilbeam CC, Raisz LG. Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae. J Bone Miner Res 1990; 5:1183-8.
81. 1(I)procollagen and transforming growth factor-B steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 1991; 128:2723-30.
82. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 1989; 86:854-7.
83. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ. Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 1991; 49:182-7.
84. Kasperk CH, Wegedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 1989; 124:1576-8.
85. Vanderschueren D, Van Herck E, Suiker A, Visser WJ, Schot LPC, Chung K, Lucas RS, Einhorn TA, Bouillon R. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res 1993; 8:801-9.
86. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995; 10:1488-95.
87. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331:1056-61.
88. Francis RM, Peacock M, Aaron JE, Selby PL, Taylor GA, Thompson J, Marshall DH, Horsman A. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone 1986; 7:261-8.
89. Delmas P, Meunier PJ. L'osteoporose au cours du syndrome de Klinefelter. Données histologiques osseuses quantitatives dans cinq cas. Relation avec la carence hormonale. Nouv Presse Med 1981; 10:687.
90. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV. Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res 1978; 26:103-6.
91. Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadal hypogonadism and its effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 1997; 82:658-65.
92. Foresta C, Ruzza G, Mioni R. Testosterone and bone loss in Klinefelter's syndrome. Horm Metab Res 1983; 15:56-67.
93. Luisetto G, Mastrogiacomo I, Bonanni G, Pozzan G, Botteon S, Tizian L, Galuppo P. Bone mass and mineral metabolism in Klinefelter's syndrome. Osteoporos Int 1995; 5:455-61.
94. Glynn NW, Meilahn EN, Charron M, Anderson SJ, Kuller LH, Cauley JA. Determinants of bone mineral density in older men. J Bone Miner Res 1995; 10:1769-77.
95. Saville PD. Changes in bone mass with age and alcoholism. J Bone Joint Surg Am 1965; 47:492-9.
96. De Vernejoul MC, Bielakoff J, Herve M, Gueris J, Hott M, Modrowski D, Kuntz D, Miravet L, Ryckewaert A. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop 1983; 79:107-15.
97. Bikle DD, Genant HK, Cann CE, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med 1985; 103:42-8.
98. Lalor BC, France MW, Powell D. Bone and mineral metabolism and chronic alcohol abuse. Q J Med 1986; 59:497-511.
99. Slemenda CW, Christian JC, Reed T, Reister TK, Williams CJ, Johnston CC. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117:286-91.
100. Lindsell DR, Wilson AG, Maxwell JD. Fractures on the chest radiograph in detection of liver disease. Br Med J 1982; 285:597-9.
101. Crilly RG, Anderson C, Hogan D, Delaquerriere-Richardson L. Bone histomorphometry, bone mass, and related parameters in alcoholic males. Calcif Tissue Int 1988; 43:269-76.
102. Laitinen K, Lamberg-Allardt C, Tunninen R, Harkonen M, Välimäki M. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med 1992; 93:642-50.
103. Laitinen K, Välimäki M. Bone and the 'Comforts of Life'. Ann Med 1993; 25:413-25.
104. Rico H, Cabranes JA, Cabello J, Gomez-Castresana F, Hernandez ER. Low serum osteocalcin in acute alcohol intoxication: a direct effect of alcohol on osteoblasts. Bone Miner 1987; 2:221-5.
105. Peris P, Pares A, Guañabens N, Del Rio L, Pons F, Martenez de Osaba MJ, Monegal A, Caballeria J, Rodes J, Munoz-Gomez J. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res 1994; 9:1607-12.
106. Jaouhari J, Schiele F, Pirollet P, Lecomte E, Paille F, Artur Y. Concentration and hydroxyapatite binding capacity of plasma osteocalcin in chronic alcoholic men: effect of a three-week withdrawal therapy. Bone Miner 1993; 21:171-8.
107. Horber FF, Casez JP, Steiger U, Czerniack A, Montandon A, Jaeger PH. Changes in bone mass early after kidney transplantation. J Bone Miner Res 1994; 9:1-9.
108. Hawkins FC, Leon M, Lopez MB, Valero MA, Larrodera L, Garcia-Garcia I, Loinaz C, Moreno Gonalez E. Bone loss and turnover in patients with liver transplantation. Hepatogastroenterology 1994; 41:158-61.
109. Boot AM, Nauta J, Hokken-Koelega CS, Pols HAP, de Ridder MAJ, de Muinck Keizer-Schrama SMPF. Renal transplantation and osteoporosis. Arch Dis Child 1995; 72:502-6.
110. Van Cleemput J, Daenen W, Nijs J, Geusens P, Dequeker J, Vanhaecke J. Timing and quantification of bone loss in cardiac transplant recipients. Transpl Int 1995; 8:196-200.
111. Sambrook PN, Kelly PJ, Keogh AM, Macdonald P, Spratt P, Freund J, Eisman JA. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 1994; 1:116-21.
112. Henderson NK, Sambrook PN, Kelly PJ, Macdonald P, Keogh AM, Spratt P, Eisman JA. Bone mineral loss and recovery after cardiac transplantation. Lancet 1995; 346:905.
113. Muchmore JS, Cooper DKC, Ye Y, Schlegel VT, Zuhdi N. Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991; 23:1184-5.
114. Shane E, del Rivas M, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP. Osteoporosis after cardiac transplantation. Am J Med 1993; 94:257-64.
115. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993; 3:322-9.
116. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisman JA, Mancini DM, Disesa VJ, Attie MF. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994; 96:35-41.
117. Rich GM, Mudge GH, Laffel GL, LeBoff MS. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11:950-8.
118. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991; 23:1462-5.
119. Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994; 9:1097-105.
120. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WSS, Epstein S. The deleterious effects of long term cyclosporin A, cyclosporin G and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57:1231-7.
121. Compston JE, Greer S, Skingle S, Stirling DM, Price C, Friend PJ, Alexander G. Early increase in plasma parathyroid hormone levels following liver transplantation. J Hepatol 1997; in press.
122. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA. Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 1994; 4:273-6.
123. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AGR, Evans RA, McCaughan GW. Bone loss after liver transplantation. Hepatology 1991; 14:613-19.
124. Huang C-C, Greer S, Allison M, Skingle S, Alexander C, Compston JE. Mechanisms of bone loss following liver transplantation. Bone 1997; in press.
125. Deller DJ, Edwards RC, Addison M. Calcium metabolism and the bones after partial gastrectomy. II The nature and cause of the bone disorder. Australas Ann Med 1963; 12:295-309.
126. Mellström D, Johansson C, Johnell O, Lindstedt G, Lundberg P-A, Obrant K, Schoon I-M, Toss C, Ytterberg B-O. Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int 1993; 53:370-7.
127. Heath H III. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 1991; 6(suppl. 2):S63-70.
128. Parfitt AM, Rao DS, Kleerekoper M. Asymptomatic hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 1991; 6(suppl. 2):S97-101.
129. Warner J, Clifton-Bligh P, Posen S, McElduff A, Delbridge L, Reeve T. Longitudinal changes in forearm bone mineral content in primary hyperparathyroidism. J Bone Miner Res 1991; 6(suppl. 2):S91-5.
130. Peacock M, Horsman A, Aaron JE, Marshall DH, Selby PJ, Simpson M. The role of parathyroid hormone in bone loss. In: Christiansen C, ed. Osteoporosis I. Glostrup, Denmark: Department of Clinical Chemistry, Glostrup Hospital, 1984:463-67.
131. Wilson RJ, Rao DS, Ellis BI, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988; 109:959-62.
132. Pak CYC, Ohata M, Lawrence ED, Snyder W. The hypercalciurias: causes, parathyroid functions and diagnostic criteria. J Clin Invest 1974; 54:387-400.
133. Pietschmann F, Breslau NA, Pak CYC. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992; 7:1383-8.
134. Fuss M, Pepersack T, Van Geel J, Corrilain J, Vandewalle J-C, Bergmann P, Simon J. Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 1990; 46:9-13.
135. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 1990; 33:143-53.
136. Bornemann M, Saxon JR, Kidd GS II. Osteoporosis unmasked by hyperthyroidism in a young man with osteogenesis imperfecta. Arch Intern Med 1987; 147:1947-8.
137. Richens A, Rowe DJ. Disturbances of calcium metabolism by anticonvulsant drugs. Br Med J 1970; 4:73-6.
138. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 1986; 230:569-77.
139. Sheth RD, Wesolowski CA, Jacoh JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995; 127:256-62.
140. Jowsey J, Arnaud SB, Hodgson SF, Johnson KA, Beabout JW, Wahner HW. The frequency of bone abnormality in patients on anticonvulsant therapy. Electroencephalogr Clin Neurophysiol 1978; 45:341-7.
141. Johnell O, Nilsson BE, Walloe A, Wiklund PE. Bone morphology in epileptics. Calcif Tissue Int 1979; 28:93-7.
142. Landa MB, Kims MS, Bartlett C, Guay-Woodford LM. Reversible Fanconi syndrome associated with valproate therapy. J Pediatr 1993; 123:320-2.
143. Philip WJU, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS. Decreased axial and peripheral bone mineral density in patients taking long term warfarin. A case control study using dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT). Q J Med 1995; 88:635-40.
144. Slemenda CW, Miller JZ, Hui SL, Reister TK, Johnston Jr CC. Role of physical activity in the development of skeletal mass in children. J Bone Miner Res 1991; 6:1227-33.
145. Minaire P. Immobilization osteoporosis: a review. Clin Rheumatol 1989; 8(suppl. 2):95-103.
146. WHO Study Group. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. WHO Technical Report Series 843. Geneva: WHO, 1994:5-6.
147. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC, Lindsay RL. Proximal femur bone mineral levels of US adults. Osteoporos Int 1995; 5:389-409.
148. Gärdsell P, Johnell O, Nilsson BE. The predictive value of forearm bone mineral content measurements in men. Bone 1990; 11:229-32.
149. Chevallay T, Rizzoli R, Nydegger V, Slosman D, Tkatch L, Rapin C-H, Vasey H, Bonjour J-P. Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int 1991; 1:146-54.
150. Karlsson MK, Johnell O, Nilsson BE, Sernbo I, Obrant KJ. Bone mineral mass in hip fracture patients. Bone 1993; 14:161-5.
151. Genant HK, Cann CE, Pozzi-Mucelli RS, Kanter AS. Vertebral mineral determination by quantitative CT: clinical and visibility and normative data. J Comp Assist Tomogr 1983; 7:554-5.
152. Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985;6:1-7.
153. Odvina CV, Wergedal JE, Libanati CR, Schulz EE, Baylink DJ. Relationship between trabecular vertebral body density and fractures. Metab Clin Exp 1988; 37:221-8.
154. Resch A, Schneider B, Bernecker P, Battman A, Wergedal J, Willvonseder R, Resch H. Risk of vertebral fractures in men: relationship to mineral density of the vertebral body. AJR Am J Roentgenol 1995; 164:1447-50.
155. Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J, Eisman J. Prediction of osteoporotic fractures by postural instability and bone density. Br Med J 1993; 307:1111-15.
156. Mann T, Oviatt SK, Wilson D, Nelson D, Orwoll ES. Vertebral deformity in men. J Bone Miner Res 1992; 7:1259-65.
157. Johnston CC Jr, Melton LJ III, Lindsay R, Eddy DM. Clinical indications for bone mass measurements: a report from the National Osteoporosis Foundation. J Bone Miner Res 1989; 4(suppl. 2):1-28.
158. Johnston CC Jr, Slemenda CW, Melton LJ III. Clinical use of bone densitometry. N Engl J Med 1991; 324:1105-9.
159. Fujiwara S, Mizuno S, Ochi T, Sasaki H, Kodama K, Russell WJ, Hosoda Y. The incidence of thoracic vertebral fractures in a Japanese population, Hiroshima and Nagasaki, 1958-86. J Clin Epidemiol 1991; 44:1007-14.
160. Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ III. Classification of vertebral fractures. J Bone Miner Res 1991; 6:207-15.
161. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke NO, Vasikaran S, Kanis JA. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 1993; 3:138-47.
162. Lukert M. Vertebral compression fractures: how to manage pain, avoid disability. Geriatrics 1994; 49:22-6.
163. O'Neill TW, Varlow J, Felsenberg D, Silman AJ. Variation in vertebral height ratios in population studies. J Bone Miner Res 1994; 9:1895-907.
164. Scane AC, Sutcliffe AM, Francis RM. The sequelae of vertebral crush fractures in men. Osteoporos Int 1994; 4:89-92.
165. Cooper C, O'Neill TW, Egger P, Kanis J, Felsenberg D, Silman AJ and the EVOS Study Group. Vertebral deformity:clinical impact and relation to fractures at other sites. Osteoporos Int 1996; 6:S111.
166. Patel U, Skingle S, Campbell GA, Crisp AJ, Boyle IT. Clinical profile of acute vertebral compression fractures in osteoporosis. Br J Rheumatol 1991; 30:418-21.
167. Zetterberg C, Mannius S, Mellström D, Rundgren A, Astrand K. Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine 1990; 15:783-6.
168. Sherman S, Tobin JD, Hollis BW, Gundberg CM, Roy TA, Plato CC. Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res 1992; 7:1123-30.
169. Resch A, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R. Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 1992; 22:542-5.
170. Demiaux B, Arlot ME, Chapuy M-C, Meunier PJ, Delmas PD. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 1992; 74:1146-51.
171. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993; 8:643-8.
172. Seibel MJ, Woitge H, Scheidt-Nave, Leidig-Bruckner G, Duncan A, Nicol P, Zeigler R, Robins SP. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study. J Bone Miner Res 1994; 9:1433-40.
173. Fatayeri D, Cooper AM, Eastell R. Changes in bone turnover with age compared to changes in total body bone mineral content with age in men. In: Ring EFJ, Elvins DM, Bhalla AK, eds. Current Research in Osteoporosis and Bone Mineral Measurement IV: Bath Conference on Osteoporosis and Bone Mineral Measurement. London, British Institute of Radiology, 1996:22.
174. Devogelaer JP, De Cooman S, Nagant de Deuxchaisnes C. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas 1992; 15:17-23.
175. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley Jr WF. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69:776-83.
176. Isaia G, Mussetta M, Pecchio F, Sciolla A, di Stefano M, Molinatti GM. Effect of testosterone on bone in hypogonadal males. Maturitas 1992; 15:47-51.
177. Anderson FH, Francis RM, Faulkner K. Androgen supplementation in eugonadal men with osteoporosis - effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone 1996; 18:171-7.
178. Anderson FH, Francis RM, Peaston RT, Wastell HJ. Androgen supplementation in eugonadal men with osteoporosis - effects of 6 months of treatment on markers of bone formation and resorption. J Bone Miner Res 1997; 12(3):472-8.
179. Scane AC, Francis RM, Johnson FJ, Davison CE. The effects of testosterone treatment in eugonadal men with osteoporosis. In: Ring EFJ, ed. Current Research in Osteoporosis and Bone Mineral Measurement II. 1992 Bath Conference on Osteoporosis and Bone Mineral Measurement. London, British Institute of Radiology, 1992:54.
180. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid treated men. Arch Intern Med 1996; 156:1173-7.
181. Anderson FH, Francis RM, Bishop DJ, Rawlings D. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. Age Ageing 1997; 26:359-65.
182. Geusens P, Nijs J, Eben K, Joly J, Dequeker J. Cyclic etidronate and calcium in male osteoporosis. J Bone Miner Res 1994; 9(suppl. 1):S397.
183. Selby PL, Rehman MT, Economou G, Whitehouse RW, Adams JE, Adams PH, Anderson DC. Etidronate in male osteoporosis: evidence for a site specific action. 4th International Symposium on Osteoporosis, Hong Kong, 1993:197-8.
184. Lozano-Tonkin C, Garcia-Hernandez L, Gonzalez-Munoz MA. Treatment of osteoporosis (osteopenia) in adult men with disodium etidronate. Calcif Tissue Int 1994; 54(suppl. 5):451.
185. Dargie R, Gallagher S, Thomson G, Nurein AM, Graham J, Bessent R, Jenkins A, Boyce BF, Boyle IT. Response of males with osteoporosis to intermittent cyclical therapy with etidronate/calcium over 3 to 5 years. In: Ring EFJ, Elvins DM, Bhalla AK, eds. Current Research in Osteoporosis and Bone Mineral Measurement IV: Bath Conference on Osteoporosis and Bone Mineral Measurement. London, British Institute of Radiology, 1996: 140.
186. Orme SM, Simpson M, Stewart SP, Oldroyd B, Westmacott CF, Smith MA, Belcheltz PE. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation. Clin Endocrinol (Oxf) 1994; 41:245-50.
187. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995; 99:235-42.
188. Valero A, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 1995; 57:15-19.
189. Devogelaer JP, Boutsen Y, Nagant de Deuxchaisnes C. A randomized controlled trial of APD (disodium pamidronate) given intravenously with and without sodium fluoride in involutional osteoporosis. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Third International Symposium on Osteoporosis. Copenhagen 1990:1507-9.
190. Valkema R, Vismans F-JFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989; 5:183-92.
191. Devogelaer JP, Nagant de Deuxchaisnes C. Treatment of involutional osteoporosis with the bisphosphonate APD (disodium pamidronate): non-linear increase of lumbar bone mineral density. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Third International Symposium on Osteoporosis. Copenhagen 1990:504-6.
192. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988; i:143-6.
193. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991; 49:71-6.
194. Agrawal R, Wallach S, Cohn S, et al. Calcitonin treatment of osteoporosis. In: Pecile A, ed. Calcitonin. Amsterdam, Excerpta Medica, 1981:237-46.
195. Burckhardt P, Burnand B. The effect of treatment with calcitonin on vertebral fracture rate in osteoporosis. Osteoporos Int 1993; 3:24-30.
196. Dawson-Hughes B, Harris SS, Krall EA, Dallah GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670-6.
197. Heaney RP, Baylink DJ, Johnston Jr CC, Melton JL III, Meunier PJ, Murray TM, Nagant-de-Deuxchaisnes C. Fluoride therapy for the vertebral crush fracture syndrome. Ann Intern Med 1989; 111:678-80.
198. Ringe JD, Kipshoven C, Rovati L, Setnikar I. Therapy of idiopathic male osteoporosis: a 3 year study with calcium and low dose intermittent monofluorophosphate. In: Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delams PD, eds. Osteoporosis 1996. International Congress Series 118, Amsterdam, Excerpta Medica, 1996:383-90.
199. Meunier PJ, Galus K, Briancon D, Edouard C, Charhon SA. Treatment of idiopathic osteoporosis with sodium fluoride. Presented at Frances Anthony D'Anna Memorial Symposium, Detroit, Michigan, 1983:360-3.
200. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJFE. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980; 2:340-4.
201. Slovik DM, Rosenthal DI, Doppelt SH, Potts Jr JT, Daly MA, Campbell JA, Neer RM. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1986; 1:377-81.
202. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990; 70:519-27.
203. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med 1992; 232:59-64.
204. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha P, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323:1-6.
205. Eddy DM, Johnston CC, Cummings SR, Dawson Hughes B, Lindsay R, Melton LJ, et al. Osteoporosis: cost effectiveness analysis and review of the evidence for prevention, diagnosis and treatment. The basis for a guidance for the medical management of osteoporosis. Osteoporosis Int 1997; in press.
206. Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo study. J Bone Miner Res 1994; 6:761-9.
207. Mallmin H, Ljunghall S, Persson I, Naessen T, Brusemo U-B, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993; 52:269-72.